Isomorphic Labs Unveils Drug Design Engine
andsoitis · hn · 2026-07-18
Isomorphic Labs has published an article introducing its drug design engine, emphasizing it as a new phase beyond AlphaFold.
The core message is that the team is no longer limited to protein structure prediction. Instead, AI is being applied to drug design and molecular optimization, integrating structures, biology, and design processes to target a more complete R&D workflow. The article describes this engine as a new frontier, framing the transition from "seeing structures" to "designing molecules."
More from Companies & People
- Fmr. OpenAI Design Head Ian Silber, Who Led ChatGPT and Codex, to Speak at SPC — soleio · 2026-10-26
- Anthropic files S-1 with SEC, formally kicking off its IPO process — minchoi · 2026-10-26
- Silicon Valley breakdown: five Stanford-area giants worth ~$18T — FinanceYF5 · 2026-10-26
- User suspects X's bundled Grok subscription boosted tweet reach amid algorithm change rumors — talkaboutdesign · 2026-10-26
- "RIP Claude + Chrome": developer flags the end of Anthropic's browser integration — damienghader · 2026-10-26
- a16z podcast: Diode pairs AI PCB design with Brooklyn factory to revive US hardware manufacturing — MattPerault · 2026-10-26